Ignite Creation Date:
2024-05-06 @ 2:13 PM
Last Modification Date:
2024-10-26 @ 1:26 PM
Study NCT ID:
NCT04243616
Status:
RECRUITING
Last Update Posted:
2024-02-06
First Post:
2020-01-24
Brief Title:
Cemiplimab in High Risk or Locally Advanced Hormone Receptor Positive HER2 Negative or Triple-Negative Breast Cancer
Sponsor:
Medical College of Wisconsin
Organization:
Medical College of Wisconsin
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-05
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-24
First Submit QC Date:
January 24 2020
Study First Post Date:
2020-01-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-02
Last Update Post Date:
2024-02-06
Last Update Post Date Type:
ACTUAL